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Abstract
Background: This study examined the osteoinductive activity of demineralized dentin matrix (DDM) from human
and polydeoxyribonucleotide (PDRN) for nude mice.
Methods: Twenty healthy nude mice, weighing about 15~20 g, were used for the study. DDM from human and
PDRN were prepared and implanted subcutaneously into the dorsal portion of the nude mice. The nude mice were
sacrificed at 1, 2, and 4 weeks after grafting and evaluated histologically by hematoxylin-eosin and Masson’s
trichrome staining. The specimens were also evaluated via a histomorphometric study.
Results: The DDM and PDRN induced new bone, osteoblasts, and fibroblasts in soft tissues. The histological findings
showed bone-forming cells like osteoblasts and fibroblasts at 1, 2, and 4 weeks. New bone formation was observed in
the histomorphometric study. In particular, the ratio of new bone formation was the highest at 2 weeks compared
with the first week and fourth week.
Conclusions: In this study, we showed that the PDRN used in this experimental model was able to induce bone
regeneration when combined to the DDM.
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Background
As an in vivo material for regeneration of tissue, poly-
deoxyribonucleotide (PDRN) is a DNA polymer with
various different lengths used for wound healing and
beauty through licenses as medicine in Europe, etc. [1].
It is known that if PDRN is used clinically, it has the
function of shortening the healing period, normalizing
tissues, and quick wound closure in diabetic foot ulcer,
and is effective for contused wound and decubitus, wound
healing, various scars, fine wrinkles, skin aging, skin pho-
toaging, skin elasticity improvement, rapid healing after
skin and plastic surgery procedures, alopecia, and blood
circulation improvement [1]. Also, PDRN can be safely ap-
plied to a clinical setting because its activation disappears
when it is orally administered and digested, and it is
absorbed into the skin through injection and spread onto
the skin and maintains activation even after high
temperature sterilization [1].
Research on such special abilities of PDRN and trials
to use it for treatment by working it on fibroblasts and
promoting secretions of cell growth factor, as well as for
beauty and wound healing, are active across the surgical
field.
However, there has been a lack of academic studies or
publishing on PDRN’s tissue regeneration function, espe-
cially bone generation, in the dental area where regener-
ation of bone tissue is essential, particularly in the oral
and maxillofacial surgery, despite the development of
various other graft materials.
In the oral and maxillofacial field, a lot of efforts have
been made to form the bone more effectively, more
rapidly, and in a more desired way for a more aesthetic
regeneration of maxillary bone defects, along with the
popularization of dental implants. In particular, human
demineralized dentin matrix (DDM), announced through
various research studies, includes multiple bone growth
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factors including type I collagen and BMP preserved in
dentin, and thus helps in the rapid regeneration of alveolar
bone and bone formation [2, 3]. Also, as it does not have a
foreign body reaction and is biocompatible, it was used as
a carrier to prevent the absorption of PDRN used in this
study and to grant manipulability.
The purpose of the study was to jointly implant PDRN
and DDM which was made from a human’s extracted
tooth under the skin of the nude mice and investigate





Twenty 4-week-old nude mice weighted about 15~20 g
from Orient Bio Inc. (Seoul, Korea) were used as experi-
mental animals and laboratory animals. After a 5-day
adaptation period followed by confirmation of absence of
natural abnormality, they were used for the experiment.
They were raised with a free supply of water and solid feed
in an environment of 22 °C average room temperature on
a 12-h light-dark cycle. The policies of the Korean Associ-
ation for Laboratory Animal Science and the laws related
to animal experiments were observed.
Preparation of human DDM
A tooth extracted from a human was delivered in a state
of being soaked in 70 % ethyl alcohol to a treating agency
(Korea Tooth Bank Co., Seoul, Korea). Attached foreign
substances such as soft tissue or dental calculus were
removed, and then it was divided into crown and root and
each part went through a crushing process. The 1~2-mm-
sized crushed particles were put in distilled water and
hydrogen oxide solution, and the remaining foreign
substances were removed from it by washing with an
ultrasonic cleaner. The washed particles were dehydrated
with ethyl alcohol and went through defatting using an
ethyl ether solution. The particles that completed all the
processes up to this underwent lyophilization, and ethyl-
ene oxide gas sterilization was performed. Finally, the
particles arrived at the laboratory in a packing state and
were used for the implant process.
Preparation of PDRN
A 1.875 w/v% polydeoxyribonucleotide solution (Placentex
Integro, Mastelli Srl, Sanremo, Italy) was prepared.
Research methods
Subcutaneous implant
Pentobarbital sodium (Nembutal, 43 mg/kg, Dainabot
Co., Japan) diluted in sterile water for injection was
injected into the abdomen to induce general anesthesia,
and then the surgical site was sterilized and isolated.
The dorsal portion was incised, and a subcutaneous
pouch was formed in both sides. DDM, which was wet
with 1.875 w/v% polydeoxyribonucleotide solution, 10 μg/
ml, was implanted into the subcutaneous pouch, and the
cut was sutured with nylon thread. And antibiotic oint-
ment was applied to prevent postoperative infection.
Manufacturing and observation of tissue samples
Experimental animals were sacrificed at 1, 2, and 4 weeks,
and DDM and neighboring tissue were immediately col-
lected. The collected tissue was fixated in 10 % buffered
formalin for more than 10 days. It was demineralized
using formic acid and dehydrated with ethanol and
embedded in paraffin to make the specimens. After
hematoxylin-eosin and MT staining, the specimens were
histopathologically observed with an Olympus BX-51
optical microscope (Olympus Co., Tokyo, Japan).
Histomorphometric analysis
The implanted PDRN causes an angiogenesis phenomenon
in neighboring soft tissue and induces [4, 5] new blood ves-
sels to the implant site and differentiates [6–8] undifferenti-
ated mesenchymal cells of the host into fibroblast and
osteoblast, and then differentiated bone formation cells
form new bones such as osteoid. Therefore, to investigate
the quantitative level of bone-forming cells around DDM,
the value derived from dividing the number of bone-
forming cells around dentin particles by the number of
dentin particles was expressed as a graph (Fig. 6). Also, the
specimens were augmented to the ×100 magnification of
an optical microscope, and six points per week were ran-
domly selected from the specimens at 1, 2, and 4 weeks
and their digital image was obtained with a digital camera
attached to the microscope. And then NB%, the area of
newly formed mineralized bone to obtained image area,
was calculated and analyzed using an image analysis




As for histopathological findings, a fibrous capsule
which was well-bounded with neighboring tissue was
observed to be surrounding the implant material and
voids between implant materials and fibrous soft tissue,
which played an important role in supplying the blood
vessels and cells, were well developed. In addition, the
vicinity of dentin particles with well-developed dentinal
tubules was surrounded by fibroblast and osteoblast,
where new bone being slightly formed was observed
(Figs. 1 and 2).
Much greater bone-forming cells were observed in the
second week than in the first week, and development of
the blood vessels and newly formed collagen matrix were
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observed between soft tissues surrounding dentin parti-
cles (Figs. 3 and 4).
In addition, the deposition and calcification of new
bone matrix were observed along with the absorption of
dentin particles by osteoclast around bone implant
materials and a considerable amount of osteoid found in
the area which was occupied by soft tissue (Fig. 5).
Histomorphometric observation
The total number of cells (osteoblast, fibroblast) around
DDM particles was divided by the number of particles
observed in the samples and then multiplied by 10. With
the average value of these being 10, 20, and 23 at 1, 2, and
4 weeks, respectively, a lot of the cells involved in bone
induction were formed around particles and increased as
time went by (Fig. 6). In addition, the area ratio of new
bone was 7, 20, and 17 % at 1, 2, and 4 weeks, respectively,
showing the highest value at 2 weeks (Fig. 7).
Discussion
In this study, by implanting DDM combined with PDRN
into the subcutaneous soft tissue of nude mice, we could
confirm that bone-forming cells were supplemented and
differentiated into osteoblast around graft materials, and
then new bone was formed. In other words, we could con-
firm osteoinduction which induced bone formation. As
for the substances showing such osteoinduction, there are
bone morphogenetic proteins (BMPs), platelet-derived
growth factors (PDGF), insulin-like growth factors (IGF),
fibroblast growth factors (FGF), epidermal growth factors
(EGF), transforming growth factor or tumor growth factor
(TGF), retinoic acid, etc. [9]. Of these, BMP in particular
is widely known to induce bone-forming cells when it is
implanted into the subcutaneous areas without the bone
or under muscles, and its excellent effect in experiments
and clinical settings has already been proved in oral and
maxillofacial field [10].
Meanwhile, the PDRN used in this study was an
activation component which was included in the materials
Fig. 1 Histologic finding of DDM with PDRN after 1 week (H-E stain,
×500). Dense fibrous tissues with moderate blood vessels and newly
attached osteoblast were observed around dentin particles
Fig. 2 Histologic finding of DDM with PDRN after 1 week (H-E stain,
×100). Well-organized fibrous capsules are seen around the whole
grafted materials. This showed little voids in the central area of grafted
materials where it is difficult for the blood vessels to invade. The fibrous
capsules around each particle are relatively tight and intimated
Fig. 3 Histologic finding of DDM with PDRN after 2 weeks (H-E xstain,
×500). The finding showed fibroblast-like cells before phenotypic
transformation and activated osteoblast-like cells
Fig. 4 Histologic finding of DDM with PDRN after 2 weeks (H-E stain,
×500). Newly deposited and produced collagen matrix on dentin
particles was observed
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used for healing of cuts and skin regeneration and was
composed of parts of low molecular DNA. As purine and
pyrimidine nucleotides are formed as a polymer of deoxy-
ribonucleotides which are composed of 50~2000 bases
with a combined form via phosphodiester combination,
they supply purine and pyrimidine as well as deoxyribo-
nucleotides and deoxyribonucleosides [11]. It is reported
that as for PDRN, nucleotides and ne growth of various
shapes of cells, synthesis of nucleic acid and healing of
cuts [12, 13], salvage pathways to create nucleic acid with
low energy consumption [14, 15], and activate A2 puriner-
gic receptors [16]. Also, other reports state that it has an
effect on chronic cuts and burns [17, 18].
With many recent studies highlighting the importance
of extracellular nucleotides and nucleosides which newly
stimulate cell growth, Guizzardi et al. [8] reported that
PDRN stimulated fibroblast and collagen by stimulating
the aforementioned purinergic receptor system. They
evaluated the effect of PDRN in human osteoblast
cultured in an experiment and confirmed that PDRN
promoted cell growth through the result that a high in-
crease of growth of osteoblast in a PDRN-administered
group compared to a control group was seen in their
experiment focusing on cell division and alkaline phos-
phatase activity. In particular, although PDRN-treated
cells showed low phosphate activity in the result of the
sixth day compared to the control group, alkaline phos-
phatase activity was shown to gradually increase from
the experiment starting day to the 10th day overall, and
from these data, PDRN was proved to work as an osteo-
blast growth stimulant. Sini et al. [6] investigated the
effect of Oligo-composite and PDRN on growth and
protein secretion of cultured human skin fibroblast and
reported that both PDRN and DNAse-treated PDRN
promoted the growth of cultured human fibroblast. Also,
the cells cultured with PDRN were shown to promote the
synthesis and secretion of protein. Thellung et al. [7]
confirmed that PDRN and adenosine increased the growth
rate of human skin fibroblast in primary culture and
reported that PDRN worked as a pro-drug which provided
a sufficient amount of mitogenic deoxyribonucleotides,
deoxyribonucleosides, and base to cultured cells.
According to these study results, we could confirm that
activation of the A2 receptor subtype purinergic receptor
through the agency of PDRN promoted propagation of
cells and tissue restoration, and it is considered that the
function of PDRN as tissue regeneration and medicine is
very positive and it can also be applied to the bone defects
in the oral and maxillofacial surgical field.
The PDRN used in this study was a material which
had been approved and used as a local treatment agent
and parenteral medicine in Italy and is known to be
effective for leg ulcers, burns, and depressed scars [1].
However, PDRN is liquid phase, and this study needed a
scaffold where cells could be attached, grow, and differ-
entiate in the cell differentiation of PDRN to investigate
bone-forming capacity, a hard tissue, while previous
studies focused on wound healing and regeneration of
soft tissue. Therefore, the author, et al., used DDM as a
scaffold. As DDM was already proved to have osteoin-
duction in itself, has little foreign body reaction, and can
emit growth factors in a sustained-release (SR) manner
Fig. 5 Histologic finding of DDM with PDRN after 4 weeks (MT-stain,
×500). The amount of new osteoid increased remarkably at 4 weeks,
with some cellular invasions into osteoid
Fig. 6 The number of cells attached to the surface of each particle
calculated at 1, 2, and 4 weeks
Fig. 7 Histomorphometric measurements of newly deposited
osteoid and bone on the surface of dentin particles at 1, 2,
and 4 weeks
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due to its porous microstructure. In addition, as it can
maintain the shape of an implant site and play the role
of structurally reinforcing defects to prevent the twist
of neighboring tissue, it can be regarded as an ideal
scaffold [2, 3].
The author, et al., could observe bone-forming cells and
the expression of new bone through a histological obser-
vation of PDRN and DDM implanted into the soft issue of
nude mice and looked into the osteoinduction of PDRN
and the possibility of DDM as an ideal carrier in a histo-
logical and histomorphometric way. In particular, taking a
short period, 4 weeks after graft and implant into soft
tissue, not hard tissue, into consideration, the hardness of
new bone was observed to have advanced considerably. In
addition, as the new growing blood vessels entered,
absorption of DDM particles were observed, and so it can
be considered that DDM plays the role of an ideal scaffold
as DDM is slowly absorbed, maintaining the space, and
replaced by new bone.
However, the limitations present in this study include
failures to verify statistical significance due to a lack of
samples in the histomorphometric analysis and to set
control group as carrier.
Conclusions
In this study, an experiment was conducted to verify the
bone-forming capacity of PDRN with DDM, a material
manufactured with demineralized dentin matrix, after
removing impurities from the extracted human teeth, and
the following results were obtained. In the result of
implanting PDRN and DDM into the subcutaneous area
of nude mice, fibroblast, osteoblast, and new bone were
induced. In the histomorphometric result, bone-forming
cells were observed at 1, 2, and 4 weeks and the formation
of osteoinduction cells increased as time went by. In the
histomorphometric result, new bone formation was con-
firmed. Among 1, 2, and 4 weeks, the new bone formation
rate was investigated to be highest at 2 weeks.
In conclusion, it was determined that DDM had excel-
lent osteoinduction when it was implanted together with
PDRN into the subcutaneous area of nude mice.
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